论文部分内容阅读
本文旨在了解罗格列酮钠对2型糖尿病患者血清中炎症因子的作用,观察使用前后患者血清CRP、IL-6、TNF-α水平的变化,并与使用二甲双胍治疗的患者进行对比。1资料与方法1.1病例选择选择2009年7～11月期间在我院住院的患者共78例,其中男40例,女38例,年龄36～69(53.6±5.2)岁。入选
This article aims to understand the effect of rosiglitazone sodium on serum inflammatory cytokines in type 2 diabetic patients and to observe the changes of serum CRP, IL-6 and TNF-α levels in patients with type 2 diabetes before and after treatment, and to compare with those treated with metformin. 1 Materials and Methods 1.1 Case Selection During the period from July to November 2009 in our hospital a total of 78 patients, including 40 males and 38 females, aged 36 to 69 (53.6 ± 5.2) years of age. Selected